The DOI matches its Crossref record.
ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTOR
Abstract
The concluded results of an experimental study are reported, confirming that the absorption of vitamin B 12 takes place in two ways: 1. through the mediation of intrinsic factor; 2. without mediation of intrinsic factor. The former mechanism allows a B 12 absorption in normally IF‐sensitive cases of pernicious anemia and in normal persons with an upper limit of about 2 μg. The latter mechanism allows an absorption of vitamin B 12 which is roughly proportional to the oral dose administered, and amounts to about 1.2% of the dose, within a very wide dose range. Thus, it is possible to increase the uptake to any desired level. This direct uptake was found to be of the same magnitude, irrespective of whether the patient had a normal absorption, was suffering from pernicious anemia with or without resistance to intrinsic factor preparations, or had some other form of disturbed B 12 absorption (idiopathic malabsorption, postoperative state after extensive gastric or intestinal resections, or ileitis). The result of a long‐term clinical trial is also reported, in which a daily oral dose of 500–1000 μg of vitamin B 12 without intrinsic factor was given to patients with pernicious anemia and other types of vitamin B 12 deficiency. The material comprised 64 patients followed for up to more than 5 years. After the remission period very few serum B 12 determinations showed borderline or subnormal values, and low levels were never of long duration. At the conclusion of the study the serum B 12 values were well within the normal range in all cases. Also the individual mean values of the B 12 determinations, made during the observation period from the second month of treatment, were normal in all cases. No neurological complications were observed. The blood values were normal in all but a few cases, in which concurrent diseases were present (malignancy, chronic infections, iron deficiency states). Experimental evidence obtained indicates that oral treatment with 500 μg of B 12 daily has also resulted in replenishment of the B 12 depots. The treatment with high oral doses of vitamin B 12 thus constitutes a convenient and completely reliable maintenance therapy in pernicious anemia and other states of B 12 deficiency, and is a fully acceptable alternative to the conventional method of vitamin B 12 injections. This type of therapy (1000 μg B 12 daily) was introduced into Sweden in 1964 and is now extensively used.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Stabler, S. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1113996 · Cited by 1,224
Green, R., Allen, L. H., Bjørke-Monsen, A.-L., Brito, A., Guéant, J.-L., Miller, J. W., Molloy, A. M., Nexo, E., Stabler, S., Toh, B.-H., et al. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.40 · Cited by 970
Prevalence of cobalamin deficiency in the Framingham elderly population
Lindenbaum, J., Rosenberg, I., Wilson, P., Stabler, S., & Allen, R. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/60.1.2 · Cited by 681
VITAMIN B12 DEFICIENCY IN THE ELDERLY
Baik, H. W., & Russell, R. M. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.357 · Cited by 525
Vitamin B12 in Health and Disease
O’Leary, F., & Samman, S. (2010) · Nutrients · doi:10.3390/nu2030299 · Cited by 524
Metadata
- Authors
- Berlin, H., Berlin, R., & Brante, G.
- Venue
- Acta Medica Scandinavica
- Publisher
- Wiley
- Published
- 1968-01-12
- Volume
- 184
- Issue
- 1-6
- Pages
- 247-258
- ISSN
- 0001-6101 (ISSN-L)
- OpenAlex
- W2064337776
- Cited by
- 220
- References
- 0
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTOR. https://app.cochat.ai/papers/10.1111/j.0954-6820.1968.tb02452.x
- The paper
- Berlin, H., Berlin, R., & Brante, G. (1968). ORAL TREATMENT OF PERNICIOUS ANEMIA WITH HIGH DOSES OF VITAMIN B12 WITHOUT INTRINSIC FACTOR. Acta Medica Scandinavica. https://doi.org/10.1111/j.0954-6820.1968.tb02452.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.